We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy rank and strong value characteristics for investors to consider today, May 2nd:
Iconix Brand Group, Inc. (ICON - Free Report) : This brand management company has a Zacks Rank #2 (Buy) and seen the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
United Rentals, Inc. (URI - Free Report) : This rental services provider has a Zacks Rank #2 (Buy) and seen the Zacks Consensus Estimate for its current year earnings rising 2.8% over the last 60 days.
Lear Corporation (LEA - Free Report) : This supplier of automotive seating systems has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 4.9% over the last 60 days.
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Top Ranked Value Stocks to Buy for May 3rd
Here are three stocks with buy rank and strong value characteristics for investors to consider today, May 2nd:
Iconix Brand Group, Inc. (ICON - Free Report) : This brand management company has a Zacks Rank #2 (Buy) and seen the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Iconix Brand Group, Inc. Price and Consensus
Iconix Brand Group, Inc. price-consensus-chart | Iconix Brand Group, Inc. Quote
Iconix has a price-to-earnings ratio (P/E) of 1.72 compared with 15.60 for the industry. The company possesses a Value Score of A.
Iconix Brand Group, Inc. PE Ratio (TTM)
Iconix Brand Group, Inc. pe-ratio-ttm | Iconix Brand Group, Inc. Quote
United Rentals, Inc. (URI - Free Report) : This rental services provider has a Zacks Rank #2 (Buy) and seen the Zacks Consensus Estimate for its current year earnings rising 2.8% over the last 60 days.
United Rentals, Inc. Price and Consensus
United Rentals, Inc. price-consensus-chart | United Rentals, Inc. Quote
United Rentals has a price-to-earnings ratio (P/E) of 9.52, compared with 16.60 for the industry. The company possesses a Value Score of A.
United Rentals, Inc. PE Ratio (TTM)
United Rentals, Inc. pe-ratio-ttm | United Rentals, Inc. Quote
Lear Corporation (LEA - Free Report) : This supplier of automotive seating systems has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 4.9% over the last 60 days.
Lear Corporation Price and Consensus
Lear Corporation price-consensus-chart | Lear Corporation Quote
Lear has a price-to-earnings ratio (P/E) of 9.73, compared with 11.00 for the industry. The company possesses a Value Score of A.
Lear Corporation PE Ratio (TTM)
Lear Corporation pe-ratio-ttm | Lear Corporation Quote
See the full list of top ranked stocks here
Learn more about the Value score and how it is calculated here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>